Fulton Breakefield Broenniman’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBDX
Fulton Breakefield Broenniman's IBDX Position: Q3 2026 in Review
Fulton Breakefield Broenniman increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 5% in Q3 2026, buying an estimated $110K and bringing the position to 93,019 shares worth $2.24M. The position accounts for 0.13% of the portfolio, ranked #78.
Fulton Breakefield Broenniman first reported a position in IBDX in Q4 2024 and has held it in 8 quarters since. 201 funds tracked by Wall St. Rank hold IBDX as of Q3 2026.
- Fulton Breakefield Broenniman held 93,019 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.24M as of Q3 2026.
- Fulton Breakefield Broenniman bought 4,451 iShares iBonds Dec 2032 Term Corporate ETF shares in Q3 2026, an estimated $110K.
- iShares iBonds Dec 2032 Term Corporate ETF made up 0.13% of Fulton Breakefield Broenniman's portfolio in Q3 2026, its #78 holding.
- Fulton Breakefield Broenniman first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2024 and has held it in 8 quarters since.
- 201 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q3 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q3 2026, filed 3 Nov 2026.